首页|期刊导航|中医肿瘤学杂志|旴江流派代表性医家治疗消化系统疾病的用药规律及其对现代消化系统肿瘤治疗的启示

旴江流派代表性医家治疗消化系统疾病的用药规律及其对现代消化系统肿瘤治疗的启示OA

Medication Rules of Representative Physicians of the Xujiang School in Treating Digestive System Diseases and Their Implications for the Treatment of Modern Digestive System Tumors

中文摘要英文摘要

目的 挖掘旴江流派代表性医家治疗消化系统疾病的用药规律与学术思想,探讨其对现代消化系统肿瘤治疗的启示,为临床诊疗提供参考.方法 以8位旴江流派代表性医家的著作为研究对象,提取治疗消化系统肿瘤相关病证的处方,运用Excel、SPSS软件对药物频次、性味、归经进行统计,并通过关联规则、聚类分析挖掘核心用药组合,提炼其辨治思想对现代肿瘤治疗的启示.结果 共纳入250首方剂,涉及中药289味,总用药频次2 650次.高频药物(频次≥20)35味,包括甘草、陈皮、当归等;药性偏温、平;药味多辛、苦、甘;主归脾、胃、肝、肺经;功效以补虚药、理气药、活血化瘀药为主.关联规则显示,两味药组合以当归-川芎关联最强,三味药以陈皮-白术-茯苓关联最强;聚类分析得到6组核心药物组合.学术思想方面,旴江医家认为此类病证核心病机为脾胃受损、气机紊乱、痰瘀毒结,由饮食不节、外邪侵袭、情志内伤、正气亏虚、瘀毒积滞诱发;形成了以顾护脾胃为核心、地域体质为基础、脉诊辨证为枢机,多法联用、融汇儒释道思想的特色诊疗体系,对现代肿瘤诊疗的启示为注重调理脾胃、扶正祛邪,以温平用药为基,辛开苦降、气血同调.结论 旴江医家治疗消化系统相关病证的学术经验对现代肿瘤防治具有指导价值,其用药规律可为临床辨治消化系统肿瘤提供思路借鉴.

Objective To explore the medication rules and academic thoughts of representative physicians of the Xujiang school in treating digestive system diseases,and to explore their implications for the treatment of modern digestive system tumors,so as to provide references for clinical diagnosis and treatment.Methods The medical works of eight representative physicians of the Xujiang school were taken as the research objects,and prescriptions for conditions highly relevant to digestive system tumors were extracted.Excel and SPSS software were applied for statistical analysis of medication frequency,nature,flavor,and meridian tropism of the included herbs.Core medication combinations were mined via association rules and cluster analysis,and the implications of their syndrome differentiation and treatment thoughts on modern tumor therapy were extracted.Results A total of 250 prescriptions were included,involving 289 Chinese medicinal herbs with a total medication frequency of 2 650 times.There were 35 high-frequency herbs(frequency≥20),including Glycyrrhizae Radix et Rhizoma,Citri Reticulatae Pericarpium,Angelicae Sinensis Radix,etc.The medicinal natures were mainly warm and neutral;the flavors were predominantly pungent,bitter,and sweet;the meridian tropisms mainly focused on spleen,stomach,liver,and lung meridian.The main efficacy categories were deficiency-tonifying herbs,qi-regulating herbs,and blood-activating and stasis-resolving herbs.Association rule analysis showed that the strongest two-herb combination was Angelicae Sinensis Radix-Chuanxiong Rhizoma,and the strongest three-herb combination was Citri Reticulatae Pericarpium-Atractylodis Macrocephalae Rhizoma-Poria.Six groups of core medication combinations were obtained by cluster analysis.In terms of academic thoughts,the Xujiang physicians believed that the core pathogenesis of such diseases was impairment of spleen and stomach,disorder of qi movement,and accumulation of phlegm,blood stasis,and toxin,induced by improper diet,invasion of exogenous pathogens,emotional internal injury,deficiency of vital qi,and stagnation of blood stasis and toxin.A distinctive diagnosis and treatment system has been formed with spleen and stomach protection as the core,regional constitution as the basis,pulse examination and syndrome differentiation as the pivotal approach,utilizing multiple methods in combination,and integrating Confucianism,Buddhism,and Taoism.The implications for the diagnosis and treatment of modern digestive system tumors lie in the emphasis on regulating spleen and stomach,strengthening vital qi to eliminate pathogenic factors,using warm and neutral medication as the basis,and combining pungent dispersing and bitter descending while regulating both qi and blood.Conclusion The academic experience of the Xujiang physicians in treating digestive system related syndromes has guiding value for the prevention and treatment of modern tumors,and their medication rules can provide references for clinical syndrome differentiation and treatment of digestive system tumors.

谢峰;李志明

江西中医药大学临床医学院,江西 南昌 330004江西中医药大学附属医院肿瘤科,江西 南昌 330019

医药卫生

旴江医学消化系统肿瘤数据挖掘用药规律学术思想

Xujiang medicinedigestive system tumorsdata miningmedication rulesacademic thoughts

《中医肿瘤学杂志》 2026 (2)

22-29,8

江西省重点研发计划项目(编号:S2024ZPYFB0457)第五批全国中医临床优秀人才研修项目(编号:国中医药人教函[2022]1号)。

10.19811/j.cnki.ISSN2096-6628.2026.03.004

评论